Mar 25, 2020
Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Mar 25, 2020
Aeroflow Healthcare Announces Partnership with Oventus Medical
Mar 19, 2020
BetterNight Comprehensive Sleep Solutions Announces COVID-19 Action Plan
Mar 18, 2020
GNO Snoring and Sinus - Ear, Nose and Throat (ENT) Doctor - Launches New Content Driven Website
Mar 04, 2020
Better Sleep With Saffron
Feb 29, 2020
Innovative Treatments For Sleep Apnea Featured On "In Depth" With Host Laurence Fishburne
Feb 27, 2020
FDA Reminds Patients that Devices Claiming to Clean, Disinfect or Sanitize CPAP Machines Using Ozone Gas or UV Light Have Not Been FDA Authorized
Feb 11, 2020
InventHelp Inventor Develops Comfortable Anti-Snoring Device (LAX-1112)
Feb 03, 2020
Shift Workers At Risk for Heart Disease, Stroke and Type 2 Diabetes
Jan 29, 2020
The Bongo Rx, a Game-Changing Sleep Apnea Device, Nominated for a Prestigious Edison Award
Jan 26, 2020
CPAP Store USA's Press Release: ResMed Launches AirFit F30i, Its First Tube-up Full Face CPAP Mask
Jan 22, 2020
Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Jan 17, 2020
Alaxo NA Announces Dr. K.J. Lee as Chief Educational Advisor
Jan 09, 2020
JOMS study: Jaw surgery improves quality of life in obstructive sleep apnea patients
Jan 08, 2020
GNO Snoring and Sinus Offers New Laboratory Test for Chronic Sinusitis
Jan 02, 2020
OPOS-Fullpower launches "The First 24/7 Opioid Compliance Solution"
Dec 27, 2019
Pivotal Phase 3 Study of DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia Disorder Published in JAMA Network Open
Dec 23, 2019
U.S. FDA Approves Eisai's DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia in Adult Patients
Dec 11, 2019
Restless Leg Syndrome Product Moves to 1st Place in Ratings from TopConsumerReviews.com
Nov 26, 2019
Positive Airway Pressure Devices Market Size Worth $2.7 Billion by 2025: Grand View Research, Inc.